Living Conditions and Breast Cancer

Completed

• Conditions: Breast Neoplasms

• Registration Number: NCT01626950
• Lead Sponsor: Centre Hospitalier Universitaire de Nīmes

Brief Summary

The main objective of this study is to estimate of the link (odds ratio) between the precariousness defined by the score SPICE (2 groups: precarious and insecure) and stage at diagnosis (2 groups: CAS: stages 1 or 2 the "good prognosis "versus the witnesses: stage 3 or 4 bad prognosis).

Detailed Description

Our secondary objectives include:

* To study the link between cancer stage at diagnosis and diverse parameters describing living conditions

* To construct a new score for social fragility based on new data collected in this study, and to compare this score with the EPICES score

* To study patient quality of life at study baseline

Study Timeline

• Study Start: 2012-05
• Study First Submitted: 2012-06-21
• Study First Submitted QC: 2012-06-21
• Study First Posted: 2012-06-25
• Primary Completion: 2013-11
• Study Completion: 2013-11
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-25
• Last Update Posted: 2015-03-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 684

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The odds ratio for having a stage I-II diagnosis versus a stage III-IV diagnosis according to EPICE score category (social fragility versus no social fragility).	Baseline (Day 0; cross-sectional study)	The main criterion is the estimation of the link (odds ratio) between the precariousness defined by the score SPICE (2 groups: precarious and insecure) and stage at diagnosis (2 groups: CAS: stages 1 or 2 the "good prognosis "versus the witnesses: stage 3 or 4 bad prognosis).

Trial Locations

Locations (3)

IURC - Laboratoire de Biostatistique d'Epidémiologie et de Recherche Clinique; 🇫🇷 Montpellier Cedex 5, France

Equipe Démographie Santé; 🇫🇷 Montpellier Cedex 5, France

Registre Tumeurs de l'Hérault; 🇫🇷 Montpellier Cedex 5, France